Increased proportion of circulating non-22-kilodalton growth hormone isoforms in short children: A possible mechanism for growth failure

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 9, 1997, Pages 2944-2949

  Boguszewski, Cesar L ^a,b   Jansson, Chatarina ^a   Boguszewski, Margaret C S ^a   Rosberg, Sten ^a   Carlsson, Björn ^a   Albertsson Wikland, Kerstin ^a   Carlsson, Lena M S ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; FEMALE; GROWTH DISORDER; GROWTH HORMONE RELEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SHORT STATURE; SMALL FOR DATE INFANT; TURNER SYNDROME;

ADOLESCENT; BODY HEIGHT; CHILD; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; ISOMERISM; MALE; MOLECULAR WEIGHT; OSMOLAR CONCENTRATION; SEX CHARACTERISTICS; TURNER SYNDROME;

EID: 0030930619     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.9.2944     Document Type: Article

References (47)

1. Baumann G. 1991 Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endoc Rev. 12:424-449.
2. Lewis UJ, Sinha YN, Haro LS. 1994 Variant forms and fragments of human growth hormone in serum. Acta Pediatr. 399(Suppl):29-31.
3. Charrier J, Martal J. 1988 Growth hormones. I. Polymorphism [Minireview]. Reprod Nutr Dev. 28:857-887.
4. Jansson C, Boguszewski CL, Rosberg S, Carlsson LMS, Albertsson-Wikland K. 1997 Growth hormone (GH) assays: influence of standard preparations, GH isoforms, assay characteristics, and GH-binding protein. Clin Chem. 43:950-956.
5. Baumann G. 1990 Growth hormone binding proteins and various forms of growth hormone: implications for measurements. Acta Paediatr Scand. 370(Suppl):72-80.
6. Chatelain P, Bouillat B, Cohen R, et al. 1990 Assay of growth hormone levels in human plasma using commercial kits: analysis of some factors influencing the results. Acta Paediatr Scand. 370(Suppl):56-61.
7. Singh RNP, Seavey BK, Lewis LJ, Lewis UJ. 1983 Human growth hormone peptide 1-43:isolation from pituitary glands. J Prot Chem. 2:525-536.
8. Lewis UJ, Markoff E, Culler FL, Hayek A, Vanderlaan WP. 1987 Biologic properties of the 20k-dalton variant of human growth hormone: a review. Endocrinol Jpn. 34(Suppl 1):73-85.
9. Baumann G, Shaw MA. 1990 Plasma transport of the 20.000-dalton variant of human growth hormone (20K): evidence for a 20K-specific binding site. J Clin Endocrinol Metab. 71:1339-1343.
10. McCarter J, Shaw MA, Winer LA, Baumann G. 1990 The 20,000 dalton variant of human growth hormone does not bind to growth hormone receptors in human liver. Mol Cell Endocrinol. 73:11-14.
11. Lewis UJ, Lewis LJ, Salem MAM, Staten NR, Galosy SS, Krivi GG. 1991 A recombinant DNA-derived modification of human growth hormone (hGH44-191) with enhanced diabetogenic activity. Mol Cell Endocrinol. 78:45-54.
12. Rowlinson SW, Waters MJ, Lewis UJ, Barnard R. 1996 Human growth hormone fragments 1-43 and 44-191: in vitro somatogenic activity and receptor binding characteristics in human and nonprimate systems. Endocrinology. 137:90-95.
13. Cunningham BC, Ultsch M, de Vos AM, Mulkerrin MG, Clauser KR, Wells JA. 1991 Dimerization of the extracellular domain of the human growth hormone receptor by a single growth hormone molecule. Science. 254:821-825.
14. De Vos AM, Ultsch M, Kossiakoff AA. 1992 Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science. 255:306-312.
15. Goffin V, Shiverick KT, Kelly PA, Martial JA. 1996 Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocr Rev. 17:385-410.
16. Boguszewski CL, Hynsjö L, Johannsson G, Bengtsson BA, Carlsson LMS. 1996 22-kD growth hormone exclusion assay: a new approach to measurement of non-22kD growth hormone isoforms in human blood. Eur J Endocrinol. 135:573-582.
17. Karlberg J, Fryer JG, Engström I, Karlberg P. 1987 Analysis of linear growth using a mathematical model. II. From 3 to 21 years of age. Acta Paediatr Scand. 337(Suppl):12-29.
18. Karlberg P, Taranger J, Engström I, Lichtenstein H, Svennberg-Redegren I. 1976 The somatic development of children in a Swedish urban community. Acta Paediatr Scand. 258(Suppl):1-148.
19. Karlberg J, Albertsson-Wikland K. 1996 Nutrition and linear growth in childhood. In: Bindels JG, Goedhardt AC and Visser HKA, eds. Recent developments in infant nutrition. London: Kluwer; 112-127.
20. Niklasson A, Ericson A, Fryer J, Karlberg J, Lawrence C, Karlberg P. 1991 An update of the Swedish reference standards for weight, lenght and head circumference at birth for given gestational age (1977-1981). Acta Paediatr Scand. 80:756-762.
21. Boguszewski M, Rosberg S, Albertsson-Wikland K. 1995 Spontaneous 24-hour growth hormone profiles in prepubertal small tor gestational age children. J Clin Endocrinol Metab. 80:2599-2606.
22. Albertsson-Wikland K, Rosberg S, Karlberg J, Groth T. 1994 Analyses of 24-hour growth hormone (GH) profiles in healthy boys and girls of normal stature. Relation to puberty. J Clin Endocrinol Metab. 78:1195-1201.
23. Merriam G, Wachler KW. 1982 Algorithms for the study of episodic hormone secretion. Am J Physiol. 243:E310-E318.
24. Albertsson-Wikland K, Rosberg S, Libre E, Lundgren L-O, Groth T. 1989 Growth hormone secretory rates in children as estimated by deconvolution analyses of 24-h plasma concentration profiles. Am J Physiol 257:E809-E814.
25. Bangham DR, Das REG, Schulster D. 1985 The international standard for human growth hormone for bioassay: calibration and characterization by international collaborative study. Mol Cell Endocrinol. 42:269-282.
26. Albertsson-Wikland K, Rosberg S, Jansson C, Novamo A. 1993 Time-resolved immunofluorometric assay of human growth hormone. Clin Chem. 39:1620-1625.
27. Cunningham BC, Jhurani P, Ng P, Wells JA. 1989 Receptor and antibody epitopes in human growth hormone identified by homolog-scanning mutagenesis. Science. 243:1330-1336.
28. Lewis UJ, Dunn JT, Bonewald LF, Seavey BK, Vanderlaan WP. 1978 A naturally occurring structural variant of human growth hormone. J Biol Chem. 253:2679-2687.
29. Lewis UJ, Bonewald LF, Lewis LJ. 1980 The 20,000-dalton variant of human growth hormone: location of the amino acid deletions. Biochem Biophys Res Commun. 92:511-516.
30. Kowarski AA, Schneider J, Ben-Galim E, Weldon VV, Daughaday WH. 1978 Growth failure with normal serum RIA-GH and low somatomedin activity: somatomedin restoration and growth acceleration after exogenous GH. J Clin Endocrinol Metab. 47:461-464.
31. Hayek A, Peake GT, Greenberg RE. 1978 A new syndrome of short stature due to biologically inactive but immunoreactive growth hormone. Pediatr Res. 12:413.
32. Plotnick LP, Van Meter QL, Kowarski AA. 1983 Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation. Pediatrics. 71:324-327.
33. Bright GM, Rogol AD, Johanson AJ, Blizzard RM. 1983 Short stature associated with normal growth hormone and decreased somatomedin-C concentrations: response to exogenous growth hormone. Pediatrics. 71:576-580.
34. Valenta LJ, Sigel MB, Lesniak MA, et al. 1985 Pituitary dwarfism in a patient with circulating abnormal growth hormone polymers. N Engl J Med. 312:214-217.
35. Spiliotis BE, August GP, Hung W, Sonis W, Mendelson W, Bereu BB. 1984 Growth hormone neurosecretory dysfunction: a treatable cause of short stature. JAMA. 251:2223-2230.
36. Rose SR, Ross JL, Uriarte M, Barnes KM, Cassorla FG, Cutler Jr JB. 1988 The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. N Engl J Med. 319:201-207.
37. Goddard AD, Covello R, Luoh S-M, et al. 1995 Mutations of the growth hormone receptor in children with idiopathic short stature. N Engl J Med. 333:1093-1098.
38. Woods KA, Camacho-Hübner C, Savage MO, Clark AJL. 1996 Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med. 335:1363-1367.
39. Takahashi Y, Kaji H, Okimura Y, Goji K, Abe H, Chihara K. 1996 Short stature caused by a mutant growth hormone. N Engl J Med. 334:432-436.
40. Albertsson-Wikland K, Rosberg S. 1991 Pattern of spontaneous growth hormone secretion in Turner syndrome. In: Ranke MB, Rosenfeld RG, eds. Turner syndrome: growth promoting therapies. Amsterdam: Elsevier; 23-28.
41. Van Es A, Massarano AA, Wit JM, et al. 1991 24-hour growth hormone secretion in Turner syndrome. In: Ranke MB, Rosenfeld RG, eds. Turner syndrome: growth promoting therapies. Amsterdam: Elsevier; 29-33.
42. Zadik Z, Landau H, Altman Y, Chen M, Lieberman E. 1993 Assessment of growth hormone (GH) axis in Turner syndrome using 24-h integrated concentrations of: GH, IGF-1, plasma GH binding activity, GH binding to 1M9 cells and GH response to pharmacological stimulation. In: Hibi I, Takano K, eds. Basic and clinical approach to Turner syndrome. Amsterdam: Elsevier; 261-267.
43. Strasburger CJ. 1990 Antigenic epitope mapping of the human growth hormone molecule: a strategy to standardize growth hormone immunoassays. Acta Paediatr Scand. 370(Suppl):82-86.
44. Blethen SL, Albertsson-Wikland K, Faklis EJ, Chasalow FI. 1994 Circulating growth hormone isoforms in girls with Turner's syndrome. J Clin Endocrinol Metab. 78:1439-1443.
45. Chernausek SD. 1996 The growth hormone/insulin-like growth factor axis in intrauterine growth retardation: pathophysiological and therapeutic implications. Endocrinologist. 6:294-300.
46. Boguszewski M, Jansson C, Rosberg S, Albertsson-Wikland K. 1996 Changes in serum insulin-like growth factor I and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age. J Clin Endocrinol Metab. 81:3902-3908.
47. Ranke MB, Price DA, Maes M, Albertsson-Wikland K, Lindberg A. 1995 Factors influencing final height in Turner syndrome following GH treatment: results of the Kabi International Growth Study (KIGS). In: Albertsson-Wikland K, Ranke MB, eds. Turner syndrome in a life span perspective: research and clinical aspects. Amsterdam: Elsevier; 161-165.